{"name":"Gain Therapeutics, Inc.","slug":"gain-therapeutics-inc","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMihwJBVV95cUxNdlhDNXZydEFPYjZkZVBzRnNaZDNPNmp6YWZfamNUWl9fQzNraWFyVVZ3endUbnRoNlV3LUVGQ1J2LXpfQ0g5dGQ5Qm5WZWZvaS10S2d2YnBuTTljYjg3UnJ3TTYyT2hOUlJ0Z0hDaTNkUmwxTDRCQ1NJaHNpWkw4em1ybWFSRmYyeEFib0xXMXQ0d0dqVWJmVXFxa2xveFh5Z1I5VWZrY3FheEYzR2locXE4LTZNblVLQy1UbFFYUndKLTNpWE9yZFdvZll3TUZjTklUTkZlUU52M2hlZ0ZQVzA4NHluRDdUODlmeEZsSVl2Z3FfSmloU0RHc1NsbnMxR3gwM2F2MA?oc=5","date":"2026-03-28","type":"pipeline","source":"The Globe and Mail","summary":"Analysts Are Bullish on These Healthcare Stocks: Gain Therapeutics (GANX), CG Oncology, Inc. (CGON) - The Globe and Mail","headline":"Analysts Are Bullish on These Healthcare Stocks: Gain Therapeutics (GANX), CG Oncology, Inc. (CGON)","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi0gFBVV95cUxOcTk3c1NzanBmVHlkLWRLTFZsa3BGUjRBaExwekxsUDJSblotZ1gxVnl6ak5JWHVUWUpwblptY0tfSEM0UDBRT2NYdDJ4WE1FZWRaanJhZnNXYk94aHBVcDBuMEJWRVRlOUZsU1cyWWw4S3VnTEN5Y2c2SVZzM2VfazAwRXo1ajEzdEprMlIwSmRLcU51OVpnekpndVU2YTBkNmNIcDFhN1hvSi1oeVhXX0tIdnVDVDNiR3liZTZyelVtVGt3MTVRdFJhbnJGbkNpSXc?oc=5","date":"2026-03-25","type":"deal","source":"roi-nj.com","summary":"Merck buys Terns Pharmaceuticals for $6.7 billion to gain access to promising leukemia drug - roi-nj.com","headline":"Merck buys Terns Pharmaceuticals for $6.7 billion to gain access to promising leukemia drug - roi","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiigJBVV95cUxNcWJGYkhkMDNiRE5oSzVBRFFvVkJfcUd0c3c4WVJOaFN2dHNsOWZpTndVVURjaktNSmU0TDdUMUhoUlVKVWJzaTZQX3EyTENscFlDYUFuOElId1dkT015RWl5ZTNQYko1YldqekEtVVU1c1dZbHQ1N2p1WDNNOTFhbDlnbjZYdWNVaTYzaS15RzZwQWxsUVhqWS1xWldZT0lTR1B4WEpjVDZ5RDV1bkE0eXFpVUJ1SXg3UzF4ZWt4SFZuTHNtejVpdlFwYXUxa2xoeTNsNE5uNHJtbWkzaGdlaFZoelkwaTJOMVpLaTNvMHl3SVhLVl9wcU9SeTlYa1c1WlRSZ0hLMm56QQ?oc=5","date":"2026-03-22","type":"pipeline","source":"The Globe and Mail","summary":"Analysts Are Bullish on Top Healthcare Stocks: Perspective Therapeutics (CATX), Gain Therapeutics (GANX) - The Globe and Mail","headline":"Analysts Are Bullish on Top Healthcare Stocks: Perspective Therapeutics (CATX), Gain Therapeutics (GANX)","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMitwFBVV95cUxQdjhoMzlrMGh2YzhwdDdvNzFSLXVsYTdXX3BDdXlsMGRhZE9YckJBUXFEeG5fRG5CQVRKcGQtT2xWRkppdWFPV2F5S3oyNzNhNEw1ZWV3WWdvY1hVWFZ6RzBKSlhKSXFqX3JmYnpLeC00TGNtM05WaXFkaDlBZ2xWSjhESkhrWk1QN05Md2ROOXE4QktlTERLNTNOTFBQLW13b0FIMzJzRi1WOTMwekp4R0stMjF3a0E?oc=5","date":"2026-03-12","type":"trial","source":"Stock Titan","summary":"Experimental Parkinson’s drug GT-02287 moves toward Phase 2 test - Stock Titan","headline":"Experimental Parkinson’s drug GT-02287 moves toward Phase 2 test","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMikgFBVV95cUxPRWY0eE54SGVGN0xLaEdKbkhjMWJrVGNmelNfSVNuQWtEdDRoWmJZYnFQSmRUSTVUaEtyUDRjS2wyM2E3YXl4VWZCYzRBRUVZU2RLOGs5T2FVaGFyN3FycG5uTHM5YWtZX1pmMXZXdnpZUHgycWNhV1dkdmt6NExTdFJ2YkFtbEVUdWZhLWNjR0Vxdw?oc=5","date":"2026-02-20","type":"pipeline","source":"Yahoo Finance","summary":"Recursion Pharmaceuticals (RXRX) Stock Sinks As Market Gains: What You Should Know - Yahoo Finance","headline":"Recursion Pharmaceuticals (RXRX) Stock Sinks As Market Gains: What You Should Know","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMikwFBVV95cUxNQVNxWm1xS1otWGVzRjZzclZpVTZETFRQUE82Yy1melk4d3pwRWFaYl81NWpLZHNNaTJFdzZPTlRNYUdtRUdRWi0xXy1hU0pvTUF2VTRwcjJaZmFWak44N1ZmNGc0Y0ZXLWdPYm9jT2dUYVMwNHczc0h2RGF4TUxVdjBSZDl2alQ2dXM1djZleFJnTEk?oc=5","date":"2026-01-27","type":"earnings","source":"Yahoo Finance","summary":"A Look At Apellis Pharmaceuticals (APLS) Valuation As GAAP Profitability And Syfovre Commercialization Gain Traction - Yahoo Finance","headline":"A Look At Apellis Pharmaceuticals (APLS) Valuation As GAAP Profitability And Syfovre Commercialization Gain Traction","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMilAFBVV95cUxNZE81ektuTmhZTzJWZUZIT2hvWFItOWZrb2dFUEtWVE1EVWo3RVVha2VNY3hKWHpCNUp5QkZONUdnbzRXdEFnLVctcnNNYnktWFhBSGtTQ0pIQS15aEtXdjNRVVhISjc3TTllaUFUTFdPYm11aDJGZlFRWEhVcEFKRVdTV3JrR2dRYnV5cUJTRVRmWDc4?oc=5","date":"2026-01-11","type":"pipeline","source":"Yahoo Finance","summary":"Reviva Pharmaceuticals Holdings (RVPH) Records 37% Gain So far in 2026 - Yahoo Finance","headline":"Reviva Pharmaceuticals Holdings (RVPH) Records 37% Gain So far in 2026","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiggFBVV95cUxPVmpPTWZVUHBVQURLZUhQY3FEVDZTZl9jSWVxN2xKWFVoMGpyNUxTZTRPTDV1V0twMnd6Q1Y5aHJoRHQzVEpMUEVYTU9vZi1hMHlNdU50aktyXzFrQUFkV1FGSGlRaGoxekhiMEw0d292emNnWTJ2akhMQUNYN0tCZmtB?oc=5","date":"2026-01-08","type":"pipeline","source":"Yahoo Finance","summary":"Following a 13% decline over last year, recent gains may please Zentalis Pharmaceuticals, Inc. (NASDAQ:ZNTL) institutional owners - Yahoo Finance","headline":"Following a 13% decline over last year, recent gains may please Zentalis Pharmaceuticals, Inc. (NASDAQ:ZNTL) institution","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiywFBVV95cUxQeVlwZ0VMM3BUNGE3UzZBeHYybGR5QzZrNzdfZmhPRWhvdmFuSU95Y05vc1Z6WFdHcEpRY3lUMVd4WklYZVdVSjZTb3M5Y29PclRRQm5LRW95aEVQSW5wZHREQ0w5TnpFZ3gxbFhIMERTTWhpZDhZX19DNTZndmNNY0RZekttU0h3dFN3OHhDeXdLX1JucUQ3OXJCVC0tT2RIeV9MSmhTaWpqZkpEZkRQNVVpUUhWWHlMeVk1NzZtbUVQV3VBZkN0eUdXTQ?oc=5","date":"2025-11-26","type":"pipeline","source":"seekingalpha.com","summary":"Ironwood Pharmaceuticals: Today's Gains Seem Sustainable After Disastrous H1 2025 (IRWD) - seekingalpha.com","headline":"Ironwood Pharmaceuticals: Today's Gains Seem Sustainable After Disastrous H1 2025 (IRWD)","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi4gFBVV95cUxQR1ptbTZqU0NuMTR6WnhGaV9mWWFlMWFhLU5uZ3FyQlJ4ci0xRzRTT1V1ZzI2VHFjQTBzWHhwME10cVJKb1VZSjhfMFBxcFdkQWNYNDYyYWVJWFFYaWRaYlg2MUJJZHdwVXhnRGtLSXNackNZWGRvVGdzYzh3X3ZGZ2pPSmNmLWQ0d0tVN21VUEwzemRxbUVnMm1BNmhNc3Vldm5xdGRRWEZ0akFuWHA4Y2xlOXQ4WC01d1o0UXd6cmRmbEU1LWJ2OVVhRlktRnBSQ3RMaXFYUzRrUkg3X3Vsek9B?oc=5","date":"2025-11-07","type":"regulatory","source":"seekingalpha.com","summary":"Gain Therapeutics: Valuation Remains Low In Light Of Recently Reported Functional Improvement In PD Patients - seekingalpha.com","headline":"Gain Therapeutics: Valuation Remains Low In Light Of Recently Reported Functional Improvement In PD Patients","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMikwFBVV95cUxNeHB5VEJxc1FMU05hVWpkejBhVkJOOE9UZVo1T0d4Y0VncTlWbEo4TnRCcU9BM0hhMndOVjZpV2M5LWxRTWtJRFctVS1jZzNudFFnZUFEYzlESVNJTzU3NzRtelptbE5zamhRa0NkMTFuSzZLcWNvOU5WTnBoQ3pId2lZMjYta3JLS1Fhc1FIR0xNd0k?oc=5","date":"2025-10-20","type":"pipeline","source":"Yahoo Finance","summary":"Is Recursion Pharmaceuticals Set for Further Gains After Recent 36% Share Price Surge? - Yahoo Finance","headline":"Is Recursion Pharmaceuticals Set for Further Gains After Recent 36% Share Price Surge?","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMivgFBVV95cUxPeUVrUU1VX0VvWW9QMzJVSlJrZTVIUjB1eThMT3NHX2VzempVTUlJZy1RUEFaWl9HMHU1eU1xRjRtRHVyT0lqQXBxTmNSWDNselJfZmkwVXYwSExmdDUxTEhsOTNCdXk2ZUV0SGhyWFlZSWFEZ2pYQ0xBRXFDcTBOS2UwMkcxV05Ub2tBWnBrdGwwWXRna2RqOFphRjIzTzFYdWZhY2FKQ0NiZXh5V2R5Q3cwZDB3SnJGVS1MVWtB?oc=5","date":"2025-10-09","type":"pipeline","source":"seekingalpha.com","summary":"Recursion Pharmaceuticals: Recent Gains Mysterious Given Lack Of Overall Progress (RXRX) - seekingalpha.com","headline":"Recursion Pharmaceuticals: Recent Gains Mysterious Given Lack Of Overall Progress (RXRX)","sentiment":"neutral"}],"patents":[],"drugCount":0,"phaseCounts":{},"enrichmentLevel":0,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}